AtriCure's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
AtriCure (NASDAQ:ATRC) is scheduled to release its quarterly earnings report on February 15, 2024, with an expected EPS of $-0.23. Analysts and investors are keen on whether AtriCure will surpass this estimate and provide positive guidance for the future. Historically, AtriCure has exceeded EPS estimates, leading to significant stock price increases. However, over the last year, AtriCure's shares have declined by 21.4%, indicating potential concerns among long-term shareholders.
February 14, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AtriCure is expected to report an EPS of $-0.23 for the upcoming quarter. Historical data shows positive stock movement following earnings beats. However, the stock has experienced a 21.4% decline over the past year.
Given AtriCure's history of exceeding EPS estimates and the subsequent positive stock price reactions, there's a potential for short-term price increase if the trend continues. However, the overall negative yearly performance suggests caution, as long-term issues may still weigh on the stock.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100